Medbelle, the London and Berlin based startup which brands itself as the first ‘digital hospital’ has raised $7 million from Signals Venture Capital with the help of Talis Capital, Mutschler Ventures, IBB and Cavalry Ventures.
The startup was founded in 2016 and aims to bring patient concerns online and to provide treatment digitally, hence being more convenient for many. Via the app or website, customers can book a variety of different medical procedures, including cosmetics and bariatrics, with a view to expand this into orthopaedics and fertility. The service gives the patient more involvement and control over their own procedures. Medbelle currently only offers services to private patients but aims to eventually broaden its reach to NHS patients. Over 30,000 Brits already use the service and an extra 144,000 users are expected by 2020.
The startup boasts state of the art operating facilities and leading specialists who can be consulted at the click of a button. The service also makes diagnosis and treatment more transparent for patients as they can be involved every step of their healthcare journey through the app or website or their own personal Medbelle Care Adviser.
Daniel Kolb, co-founder and MD of Medbelle remarks that “The new capital will accelerate the development of our platform while growing Medbelle’s operating footprint. It will allow us to streamline high-quality care at scale and take even more work off the hospitals’ and specialists’ shoulders. Our technology helps them to operate more efficiently, be better-utilised and fully focused on what matters most: the best care for patients.”
Clemens Koós, investment manager at Signals Venture Capital, comments that “Major digital platforms improve customer experience in almost all industries, however, in healthcare, the digitisation of patient journeys has been heavily lagging behind until now. Medbelle’s technology and personalised care enable much simpler and more affordable medical treatments – while allowing healthcare providers to efficiently focus on treating patients. We look forward to working with the Medbelle team and co-investors in expanding the platform to include more treatment specialities and increasing its reach.”